1
Q
GOLD
A
Global initiative for
Obstructive Lung Disease
2
Q
Measurements involved in GOLD
A
- FEV1/FVC
- mMRC
- CAT
- eCOPD
3
Q
What FEV1/FVC indicates COPD
A
70%
4
Q
How is the MRC dyspnoea scale scored?
A
0 = Not troubled by breathlessness except on strenuous exercise
1 = Short of breath when hurrying or walking up a slight hill
2 = Walks slower than other people of similar age on level ground because of
breathlessness, or has to stop for breath when walking at their own pace
3 = Stops for breath after
about 100m or after a few minutes of walking on level ground
4 = Too breathless to leave the
house, or breathless when dressing or undressing
5
Q
What is given to all groups of patients for immediate relief of symptoms?
A
- Short-acting bronchodilators
e. g. SABA
6
Q
Group A
A
- 0-1 moderate exacerbations (not requiring admission to hospital)
- MRC = 0-1
- CAT < 10
7
Q
Group A - treatment
A
- A single long-acting bronchodilator
- Either LABA OR LAMA
- Long-acting is more preferred unless patients have occasional breathlessness
8
Q
Group B
A
- 0-1 moderate exacerbations (not requiring admission to hospital)
- MRC = 2 or more
- CAT = 10 or more
9
Q
Group B: treatment
A
- LABA + LAMA
- Ideally as one combined inhaler, rather than separate
10
Q
Group E
A
- 2 or more moderate exacerbations (not requiring admission to hospital)
OR - ONE severe exacerbation requiring hospital admission
- MRC = 2 or more
- CAT = 10 or more
11
Q
Group E: treatment
A
- LABA + LAMA
- However, if the blood eosinophil count is 300 or more, give LABA + LAMA + ICS (Triple therapy)
- Ideally given as a single combined product inhaler
